Andrew R Larsen et al., 2015-01: Larsen et al. show mebendazole inhibits Hedgehog signalling by suppressing primary cilium formation and slows Hh-driven medulloblastoma growth, additively with vismodegib and independently of SMO mutation.
Here, we show that mebendazole, a benzamidazole with a long history of safe use against nematode infestations and hydatid disease, potently inhibited Hh signaling and slowed the growth of Hh-driven human medulloblastoma cells at clinically attainable concentrations.
Andrew R Larsen et al., 2015-01: Larsen et al. show mebendazole inhibits Hedgehog signalling by suppressing primary cilium formation and slows Hh-driven medulloblastoma growth, additively with vismodegib and independently of SMO mutation. Study type: cell lines (Hh-driven medulloblastoma) with cilium and pathway assays. N: not applicable. Country: USA (Johns Hopkins, Baltimore). Dose: 'clinically attainable concentrations', exact values not stated in the abstract. Funder: US NIH R01CA157535 and T32 GM008752. Declared conflicts: 'Potential conflicts of interest: None.' Comparator: vismodegib, alone and in combination; SMO-mutant versus wild-type cells. This is the lead named in the prompt as 'Larsen AR et al., medulloblastoma, Mol Cancer Ther 2015' and the citation is confirmed.
